Pharmasaga Co. Ltd. (TPEX:7878)

Market Cap	12.55B
Revenue	n/a
Net Income	n/a
Shares Out	53.54M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	136,814
Average Volume	371,857
Open	234.50
Previous Close	234.50
Day's Range	228.50 - 234.50
52-Week Range	168.00 - 290.50
Beta	n/a
RSI	42.29
Earnings Date	n/a

About Pharmasaga

Pharmasaga Co. Ltd., a drug discovery and development company, focuses on developing anti-diabetic drugs. It develops Pdia4 inhibitors, which includes PS-001 for type 2 diabetes; and PS-002 for type 1 diabetes. The company was founded in 2021 and is based in Taipei, Taiwan.

• Industry: Pharmaceutical Preparations
• Founded: 2021
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7878